Advertisement

Supply Chain

Advertisement

An immunotherapy drug tested on non-small cell lung cancer patients proved so effective in a recent clinical trial that the study has been cut short and the drug is being fast-tracked for approval from the Food and Drug Administration.

Melville, N.Y.-based Henry Schein, the world's largest healthcare products and service supplier, completed its 50 percent equity investment in dental equipment and distributor One Piece, a division of J. Morita in Japan.

Advertisement